Affiance Financial’s Boston Scientific BSX Stock Holding History

Affiance Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-400	Closed	-$18.5K	–	137
2022 Q4	$18.5K	Buy	+400	New	+$17.3K	0.01%	248

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Affiance Financial's BSX Position: Q1 2023 in Review

Affiance Financial sold out of Boston Scientific (BSX) in Q1 2023, closing a stake of 400 shares — an estimated $18.5K sold.

Affiance Financial first reported a position in BSX in Q4 2022 and held it in 1 quarter. The position peaked at $18.5K in Q4 2022. 996 funds tracked by Wall St. Rank hold BSX as of Q1 2023.

Affiance Financial reported no remaining Boston Scientific position as of Q1 2023 after selling out during the quarter.
Affiance Financial sold 400 Boston Scientific shares in Q1 2023, an estimated $18.5K.
Affiance Financial first reported a position in Boston Scientific in Q4 2022 and held it in 1 quarter.
Affiance Financial's Boston Scientific position peaked at $18.5K in Q4 2022.
996 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2023.

Based on Affiance Financial's 13F filing for Q1 2023, filed 18 Apr 2023.